Cholesterol absorption and the metabolic syndrome: A new look at an old area

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 8, 2003, Pages 1314-1316

  Berglund, Lars ^a,c   Hyson, Dianne ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EDITORIAL; HUMAN; INSULIN RESISTANCE; INTESTINE ABSORPTION; METABOLIC DISORDER; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ABSORPTION; CHOLESTEROL; DIET, FAT-RESTRICTED; HYPERLIPIDEMIAS; METABOLIC SYNDROME X;

EID: 0043235676     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000087145.71160.15     Document Type: Editorial

References (38)

1. Ginsberg HN. Treatment for patients with the metabolic syndrome. Am J Cardiol. 2003;91:29E-39E.
2. Ginsberg HN. Lipoprotein physiology in non-diabetic and diabetic states: relationship to atherogenesis. Diabetes Care. 1991;14:839-855.
3. Fisher EA, Ginsberg HN. Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins. J Biol Chem. 2002;277:17377-17380.
4. Watts GF, Naoumova R, Cummings MH, Umpleby AM, Slavin BM, Sonksen PH, Thompson GR. Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjects. Metabolism. 1995;44:1052-1057.
5. Princen BHCMT, Romijn JA, Bisschop PH, de Barse MMJ, Barrett PHR, Ackermans M, Berger R, Rabelink TJ, de Sain-van der Velden MGM. Endogenous cholesterol synthesis is associated with VLDL-2 apoB-100 production in healthy humans. J Lipid Res. 2003;44:1341-1348.
6. Malmström R, Packard CJ, Watson TD, Rannikko S, Caslake M, Bedford D, Stewart P, Yki-Järvinen H, Shepherd J, Taskinen MR. Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol. 1997;17:1454-1464.
7. Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, Erdman JW Jr, Kris-Etherton P, Goldberg IJ, Kotchen TA, Lichtenstein AH, Mitch WE, Mullis R, Robinson K, Wylie-Rosett J, St Jeor S, Suttie J, Tribble DL, Bazzarre TL. AHA Dietary Guidelines: revision 2000 - a statement for healthcare professionals from the Nutrition Committee of the Am Heart Association. Circulation. 2000;102:2284-2299.
8. Quintao E, Grundy SM, Ahrens EH Jr. Effects of dietary cholesterol on the regulation of total body cholesterol in man. J Lipid Res. 1971;12:233-247.
9. National Diet-Heart Study Research Group: Faribault second study. National Diet-Heart Study final report. Circulation. 1968;37(suppl I):I-260-I-274.
10. Mattson FH, Erickson BA, Kligman AM. Effects of dietary cholesterol on serum cholesterol in man. Am J Clin Nutr. 1972;25:589-594.
11. Weggemans RM, Zock PL, Katan MB. Dietary cholesterol from eggs increased the ratio of total cholesterol to high-density lipoprotein cholesterol in humans: a meta-analysis. Am J Clin Nutr. 2001;73:885-891.
12. McNamara DJ, Kolb R, Parker TS. Batwin H, Samuel P, Brown CD, Ahrens EH Jr. Heterogeneity of cholesterol homeostasis in man: response to changes in dietary fat quality and cholesterol quantity. J Clin Invest. 1987;79:1729-1739.
13. Beynen AC, Katan MB, Van Zutphen LF. Hypo- and hyperresponders: individual differences in the response of serum cholesterol concentration to changes in diet. Adv Lipid Res. 1987;22:115-171.
14. Ginsberg HN, Karmally W, Siddiqui M, Holleran S, Tall AR, Rumsey SC, Deckelbaum RJ, Blaner WS, Ramakrishnan R. A dose-response study of the effects of dietary cholesterol on fasting and postprandial lipid and lipoprotein metabolism in healthy young men. Arterioscler Thromb. 1994;14:576-586.
15. Ginsberg HN, Karmally W, Siddiqui M, Holleran S, Tall AR, Blaner WS, Ramakrishnan R. Increases in dietary cholesterol are associated with modest increases in both LDL and HDL cholesterol in healthy young women. Arterioscler Thromb Vasc Biol. 1995;15:169-178.
16. Jones PJ. Regulation of cholesterol biosynthesis by diet in humans. Am J Clin Nutr. 1997;66:438-446.
17. Briones ER, Steiger DL, Palumbo PJ, O'Fallon WM, Langworthy AL, Zimmerman BR, Kottke BA. Sterol excretion and cholesterol absorption in diabetics and nondiabetics with and without hyperlipidemia. Am J Clin Nutr. 1986;44:353-361.
18. Gylling H, Miettinen TA. Cholesterol absorption, synthesis, and LDL metabolism in NIDDM, Diabetes Care. 1997;20:90-95.
19. Sutherland WH, Scott RS, Lintott CJ, Robertson MC, Stapely SA, Cox C. Plasma non-cholesterol sterols in patients with non-insulin dependent diabetes mellitus. Horm Metab Res. 1992;24:172-175.
20. Strandberg TE, Salomaa V, Vanhanen H, Miettinen TA. Associations of fasting blood glucose with cholesterol absorption and synthesis in non-diabetic middle aged men. Diabetes. 1996;45:755-761.
21. Simonen P, Gylling H, Howard AN, Miettinen TA. Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am J Clin Nutr. 2000;72:82-88.
22. Simonen P, Gylling H, Miettinen TA. Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetes. Obes Res. 2002;10:328-335.
23. Miettinen TA, Gylling H. Cholesterol absorption efficiency and sterol metabolism in obesity. Atherosclerosis. 2000;153:241-248.
24. Chan DC, Watts GF, Barrett PHR, O'Neill FH, Redgrave TG, Thompson GR. Relationships between cholesterol homeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndrome. Clin Science. 2003;104:383-388.
25. Bosner MS, Lange LG, Stenson WF, Ostlund RE Jr. Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectroscopy. J Lipid Res. 1999;40:302-308.
26. Miettinen TA, Gylling H. Cholesterol synthesis and absorption in coronary patients with lipid triad and isolated high LDL cholesterol in a 4S subgroup. Atherosclerosis. 2003;168:343-349.
27. Gylling H, Miettinen TA. Baseline cholesterol absorption and synthesis of cholesterol regulate its response to hypolipidemic treatments in coronary patients. Atherosclerosis. 2002;160:477-481.
28. Knopp RH, Walden CE, Retzlaff BM, McCann BS, Dowdy AA, Albers JJ, Gey GO, Cooper MN. Long-term cholesterol-lowering effects of 4 fat-restricted diets in hypercholesterolemic and combined hyperlipidemic men: The Dietary Alternatives Study. JAMA. 1997;278:1509-1515.
29. Knopp RH, Retzlaff B, Walden C, Fish B, Buck B, McCann B. One-year effects of increasingly fat-restricted carbohydrate-enriched diets on lipoprotein levels in free-living subjects. Proc Soc Exp Biol Med. 2000;225:191-199.
30. Beynen AC, Katan MB. Effect of egg yolk feeding on the concentration and composition of serum lipoproteins in man. Atherosclerosis. 1985;54:157-166.
31. Knopp RH, Retzlaff BM, Walden CE, Dowdy A, Tsunehara CH, Austin MA, Nguyen T. A double-blind, randomized, controlled trial of the effects of two eggs per day in moderately hypercholesterolemic and combined hyperlipidemic subjects consuming the NCEP Step I diet. J Am Coll Nutr. 1997;16:551-561.
32. Garber DW, Henkin Y, Osterlund LC, Darnell BE, Segrest JPP. Plasma lipoproteins in hyperlipidemic subjects eating iodine-enriched eggs. J Am Coll Nutr. 1992;11:294-303.
33. Knopp RH, Retzlaff B, Fish B, Walden C, Wallick S, Anderson M, Aikawa K, Kahn SE. Effects of insulin resistance and obesity on lipoproteins and sensitivity to egg feeding. Arterioscler Thromb Vasc Biol. 2003;23:1437-1443.
34. Sudhop T, Lütjohann D, Kodal A, Igel M, Tribble DL, Shah S, Perevozskaya I, von Bergmann K. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation. 2002;106:1943-1948.
35. Bruckert E, Giral P, Tellier P. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption. Circulation. 2003;107:3124-3128.
36. Knopp RH, Gitter H, Truitt T, Bays H, Manion CV, Lipka LJ, LeBeaut AP, Suresh R, Yang B, Veltri EP. Ezetimibe Study Group: effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia. Eur Heart J. 2003;24:729-741
37. Kosoglou T, Meyer I, Veltri EP, Statkevich P, Yang B, Zhu Y, Mellars L, Maxwell SE, Patrick JE, Cutler DL, Batra VK, Affrime MB. Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin. Br J Clin Pharmacol. 2002;54:309-319.
38. Sehayek E, Nath C, Heinemann T, McGee M, Seidman CE, Samuel P, Breslow JL. U-shape relationship between change in dietary cholesterol absorption and plasma lipoprotein responsiveness and evidence for extreme interindividual variation in dietary cholesterol absorption in humans. J Lipid Res, 1998;39:2415-2422.